Physician profile
Cyrus E Bakhit
NPI 1548295165
$7,759.78
in general payments reported to CMS, 2019-2025
34 companies · $1,521 in 2025
The $1,521 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $626 · 2020: $309 · 2021: $1,072 · 2022: $1,384 · 2023: $1,202 · 2024: $1,645 · 2025: $1,521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,368.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,110.16 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Collegium Pharmaceutical, INC. | $916.19 | 2019-2025 | Belbuca, Xtampza |
| Abbvie INC. | $853.44 | 2021-2025 | Qulipta, Ubrelvy |
| Nevro Corp. | $687.81 | 2019-2024 | Senza |
| Abbott Laboratories | $679.71 | 2019-2025 | Proclaim, Eterna |
| Ibsa Pharma INC. | $460.45 | 2021-2025 | Tirosint, Licart, Tirosint |
| Depuy Synthes Sales INC. | $289.61 | 2020-2025 | Orthovisc, Monovisc |
| Medtronic USA, INC. | $268.58 | 2019-2020 | |
| Stimwave Technologies Incorporated | $201.52 | 2021 | |
| Spinal Simplicity, LLC | $196.91 | 2022 | |
| Pfizer INC. | $143.18 | 2023-2025 | |
| Si-Bone, INC. | $133.09 | 2019-2024 | |
| Grt US Holding, INC. | $124.74 | 2021-2022 | |
| Amgen INC. | $91.16 | 2021 | |
| Boston Scientific Corporation | $81.36 | 2022-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $75.98 | 2022 | |
| Allergan, INC. | $61.74 | 2020-2022 | |
| Bioventus LLC | $47.88 | 2021-2023 | Durolane |
| Fidia Pharma USA INC. | $41.32 | 2019-2025 | Hymovis |
| Uswm, LLC | $32.70 | 2021-2022 | |
| Tersera Therapeutics LLC | $31.81 | 2025 | Prialt |
| Vertex Pharmaceuticals Incorporated | $25.67 | 2025 | |
| Mdd US Operations, LLC | $24.73 | 2019 | |
| Tonix Medicines, INC. | $23.95 | 2025 | Tonmya |
| Biohaven Pharmaceuticals, INC. | $22.63 | 2021 | |
| Merz Pharmaceuticals, LLC | $20.70 | 2021 | |
| Scilex Pharmaceuticals INC. | $20.32 | 2021 | |
| Amneal Pharmaceuticals LLC | $17.37 | 2023 | Lyvispah |
| Biodelivery Sciences International, INC. | $14.95 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.71 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.62 | 2023 | Seglentis |
| Arbor Pharmaceuticals, INC. | $11.53 | 2019 | |
| Medtronic Vascular, INC. | $11.05 | 2020 | |
| Metacel Pharmaceuticals LLC | $10.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cyrus Bakhit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.